Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

CanBas Co., Ltd. (4575) Price & Analysis

4575 Stock Chart & Stats

¥749.00-¥17.00(-2.22%)
At close: 4:00 PM EDT
JPY 700JPY 750JPY 800JPY 8503 Aug17 Aug31 Aug14 Sep28 Sep13 Oct26 Oct
Day’s Range
JPY 741.00 - JPY 779.00
52-Week Range
JPY 506.00 - JPY 991.00
Previous Close
JPY 766.00
Volume
347.00K
Average Volume (3M)
117.94K
Market Cap
JPY 14.81B
Enterprise Value
JPY 10.24B
Total Cash (Recent Filing)
JPY 1.45B
Total Debt (Recent Filing)
JPY 0
Price to Earnings (P/E)
―
Beta
0.83
Next Earnings
Nov 13, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Debt-Free Balance Sheet

The absence of reported debt reduces solvency and interest-burden risk while giving CanBas more financial flexibility than during FY2021–FY2022, when leverage was materially higher. This provides a durable balance-sheet advantage as the company continues funding its development activities.

Oncology Development Focus

A concentrated oncology focus can support deeper expertise and a clearer development strategy than a broadly diversified early-stage portfolio. Continued preclinical and clinical activity gives CanBas a defined route toward potential product commercialization, although success remains dependent on development outcomes.

External Commercialization Pathways

External collaboration provides CanBas with a route to advance candidates beyond internal research and pursue commercialization without relying exclusively on its small organization. Partnerships can broaden development capabilities and market access if the pipeline achieves sufficient clinical and commercial progress.

Bears Say

No Recent Revenue

The absence of revenue since FY2022 indicates that CanBas has not yet established a recurring commercial business base. Without product sales, the company remains dependent on development progress and external funding, making financial performance highly sensitive to the timing and success of future commercialization.

Persistent Losses

Large recurring net losses show that the current operating model is not profitable and that research and development spending has not yet translated into sustainable earnings. Continued losses can constrain strategic flexibility and require CanBas to secure additional capital before products generate meaningful revenue.

Ongoing Cash Burn And Equity Erosion

Persistent negative operating and free cash flow means the business is not self-funding, while falling equity reflects the cumulative cost of ongoing losses. Continued cash consumption increases reliance on external financing and raises the potential for future dilution if additional funding is required.

4575 FAQ

What was CanBas Co., Ltd.’s price range in the past 12 months?
CanBas Co., Ltd. lowest stock price was ¥506.00 and its highest was ¥991.00 in the past 12 months.
What is CanBas Co., Ltd.’s market cap?
CanBas Co., Ltd.’s market cap is ¥14.81B.
When is CanBas Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CanBas Co., Ltd.’s earnings last quarter?
CanBas Co., Ltd. released its earnings results on Aug 12, 2026. The company reported -¥22.07 earnings per share for the quarter.
Is CanBas Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does CanBas Co., Ltd. pay dividends?
CanBas Co., Ltd. does not currently pay dividends.
What is CanBas Co., Ltd.’s EPS estimate?
CanBas Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CanBas Co., Ltd. have?
CanBas Co., Ltd. has 19,770,655 shares outstanding.
What happened to CanBas Co., Ltd.’s price movement after its last earnings report?
CanBas Co., Ltd. reported an EPS of -¥22.07 in its last earnings report. Following the earnings report the stock price went down -1.195%.
Which hedge fund is a major shareholder of CanBas Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4575
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology